U.S. market Closed. Opens in 1 hour 23 minutes

RGEN | Repligen Corporation Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for RGEN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is strong.

Valuation (28%)

Company Industry
P/E Ratio (TTM) -393.31 49.50
PEG Ratio (TTM) 12.04 4.50
P/S Ratio (TTM) 13.24 13.78
P/B Ratio (TTM) 4.04 7.34
P/FCF Ratio (TTM) 62.12 229.30
Price to 5YR AVG Earnings Ratio 90.80 105.54
Price to 5YR AVG FCF Ratio 168.65 97.57

Profitability (15%)

Company Industry
ROA (TTM) -0.73% 6.72%
ROE (TTM) -1.04% 11.28%
Net Profit Margin (TTM) -3.37% -0.16%
ROIC 5YR AVG 12.21% 11.39%

Growth (88%)

4QTR AVG 3YR AVG 5YR AVG
EPS 89.13% 93.09% 49.09%
Revenue 2.45% 52.63% 31.42%
Net Income -48.29% 107.61% 58.03%
Cash Flow 9.79% 62.78% 39.82%

Health (65%)

Company Industry
Current Ratio (TTM) 10.44 3.26
Quick Ratio (TTM) 8.76 2.48
D/E Ratio (TTM) 0.26 0.51
Interest Coverage (TTM) -0.29 39.67
Piotroski F-Score 5 6
Altman Z-Score 6.90 27.26
LTL to 5YR AVG FCF 13.17 4.14
Shares Outstanding Growth 5YR AVG 5.03% 0.91%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙